New York State Common Retirement Fund Arbutus Biopharma Corp Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, New York State Common Retirement Fund holds 21,868 shares of ABUS stock, worth $68,884. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,868
Previous 21,868
-0.0%
Holding current value
$68,884
Previous $84,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ABUS
# of Institutions
167Shares Held
101MCall Options Held
649KPut Options Held
666K-
Morgan Stanley New York, NY22.6MShares$71.1 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.2MShares$41.7 Million22.74% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$36.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.98MShares$28.3 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.74MShares$27.5 Million4.68% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $472M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...